Laughing gas for acute suicidal thoughts
Part of Mental health clinical trials.
This study tests whether breathing a mixture of nitrous oxide (laughing gas) and oxygen can quickly reduce strong suicidal thoughts. It's for people experiencing a mental health crisis who may need fast relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe suicidal thoughts (as assessed by a doctor or questionnaire).
- Your blood homocysteine level is 14 µmol/l or below (a simple blood test).
- You are not currently pregnant or breastfeeding.
- You have not used recreational nitrous oxide (laughing gas) in the past 12 months.
- You have not taken ketamine or certain other medications recently (study team will review).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether breathing nitrous oxide can safely reduce suicidal thoughts in adults with major depression. It may help people whose depression is causing moderate to severe suicidal thinking, by studying a fast-acting treatment approach.
This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.
This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.
This study tests whether a single dose of ketamine, given by injection in the emergency department, combined with brief psychotherapy, can quickly reduce suicidal thoughts and keep you safe. It aims to find fast-acting relief for people in crisis, possibly helping you feel better sooner and reducing the risk of future attempts.
This study tests combining a specific type of therapy (BCBT-SP) with esketamine nasal spray to help people with treatment-resistant depression who are having ongoing suicidal thoughts. The goal is to see if this combination can reduce suicidal ideation more effectively than either treatment alone.
This study tests whether a single ketamine injection can quickly reduce suicidal thoughts in people waiting to be admitted to the psychiatric unit. Ketamine is a fast-acting medication that may help calm the mind during a crisis.
Hear when a new Suicidality trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.